- US12616714utility2026Enhanced Oligonucleotides for Modulating FUBP1 Expression0 cites
- US12616921utility2026Process for the Deprotection of Oligonucleotides0 cites
- US12617798utility2026Imidazopyrazne Derivatives0 cites
- US12605376utility2026Methods of Treating Relapsing Multiple Sclerosis Using an Inhibitor of Bruton's Tyrosine Kinase0 cites
- US12606584utility2026Process for the Preparation of Oligonucleotides Using Modified Oxidation Protocol0 cites
- US12606614utility2026Human Fcrn-binding Modified Antibodies and Methods of Use0 cites
- US12608807utility2026Method of Generating a Metric to Quantitatively Represent an Effect of a Treatment0 cites
- US12600712utility2026Amino-pyrimidine Amides0 cites
- US12600781utility2026Tumor-targeted Agonistic CD28 Antigen Binding Molecules0 cites
- US12595255utility2026Heteroaryl-substituted Imidazole Derivatives0 cites
- US12595295utility2026Dosing Regimes for Treatment of Synucleinopathies0 cites
- US12595294utility2026Methods to Decrease Impurities from Recombinant Protein Manufacturing Processes0 cites
- US12596118utility2026Oligonucleotides for Inducing Paternal UBE3A Expression0 cites
- US12596120utility2026Ph-gradient Spr-based Binding Assay0 cites
- US12590151utility2026Anti-human CD19 Antibodies with High Affinity0 cites
- US12577293utility2026Method for the Expression of Polypeptides Using Modified Nucleic Acids0 cites
- US12577257utility2026Heterocyclic Compounds0 cites
- US12570615utility2026Quinazolinone Derivatives0 cites
- US12565497utility2026Sulfone Derivatives0 cites
Page 1 of 14Next →